[1]
Bedoya-Trujillo, L.N. and Bedoya-Trujillo, P.N. 2021. Case report: pembrolizumab-induced Type 1 diabetes mellitus in a patient with lung adenocarcinoma. Revista Endocrino. 7, 3 (Mar. 2021), 188–192. DOI:https://doi.org/10.53853/encr.7.3.632.